Matching trials
2,411 results
- A Teleheath tDCS Approach to Decrease Cannabis Use: Complete Statistical AnalysisIndependent statistical analysis of A Teleheath tDCS Approach to Decrease Cannabis Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05005013).
- A Trial of FANG™ Vaccine for Participants With Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Trial of FANG™ Vaccine for Participants With Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01309230).
- A Trial of GC4419 in Patients With Critical Illness Due to COVID-19: Complete Statistical AnalysisIndependent statistical analysis of A Trial of GC4419 in Patients With Critical Illness Due to COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable…
- A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia: primary endpoint results, effect…
- A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of…
- A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS: Complete Statistical AnalysisIndependent statistical analysis of A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS: primary…
- A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate…
- A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing’s Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: Complete Statistical AnalysisIndependent statistical analysis of A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A-PREDICTIndependent statistical analysis of A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu’s Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Abatacept in Treating Adults With Mild Relapsing Wegener’s Granulomatosis: Complete Statistical AnalysisIndependent statistical analysis of Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00468208).
- ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI: Complete Statistical AnalysisIndependent statistical analysis of Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: Complete Statistical AnalysisIndependent statistical analysis of Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AC-170Independent statistical analysis of Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- AC105Independent statistical analysis of AC105 in Patients With Acute Traumatic Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01750684).
- Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: Complete Statistical AnalysisIndependent statistical analysis of Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00519779).
- Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Acamprosate to Reduce Symptoms of Alcohol Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate to Reduce Symptoms of Alcohol Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00106106).
- Acetazolamide Efficacy in Ataxia in PMM2-CDG: Complete Statistical AnalysisIndependent statistical analysis of Acetazolamide Efficacy in Ataxia in PMM2-CDG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04679389).
- Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ACHIEVEIndependent statistical analysis of Albumin for Intracerebral Hemorrhage Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00990509).
- ACOSOG Z1071Independent statistical analysis of ACOSOG Z1071, a phase 2 diagnostic trial evaluating sentinel lymph node surgery after chemotherapy in women with stage II, stage IIIA, or stage IIIB breast cancer.
- ACTG 175A statistical review of ACTG 175, a randomized, double-blind phase II trial of monotherapy versus combination therapy with nucleoside analogs in HIV-infected persons with CD4 cells of 200-500/mm3.
- ACTG 193AAn independent statistical analysis of ACTG 193A, a randomized, double-blind, four-arm phase 2 study comparing nucleoside treatment strategies for advanced HIV disease with CD4 ≤50/mm3.
- ACTG 320An educational statistical analysis of ACTG 320, a phase 2 study of abacavir sulfate plus indinavir sulfate plus efavirenz in HIV-infected patients, including its registry design, endpoints, planned statistical analysis, and methodological…
- ACTIVEIndependent statistical analysis of ACTIVE: Advanced Cognitive Training for Independent and Vital Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298558).
- Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp: Complete Statistical AnalysisIndependent statistical analysis of Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Acute and Residual Effects of Caffeinated Beer: Complete Statistical AnalysisIndependent statistical analysis of Acute and Residual Effects of Caffeinated Beer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515294).
- Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans: Complete Statistical AnalysisIndependent statistical analysis of Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Acute Pain Study Following Bunionectomy: Complete Statistical AnalysisIndependent statistical analysis of Acute Pain Study Following Bunionectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01333722).
- Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda: Complete Statistical AnalysisIndependent statistical analysis of Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ADAMIndependent statistical analysis of A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN: Complete Statistical AnalysisIndependent statistical analysis of ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04639024).
- ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing’s Sarcoma, and Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer: primary endpoint results, effect estimate…
- Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01206296).
- Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ADmIReIndependent statistical analysis of A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03831191).
- Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa: Complete Statistical AnalysisIndependent statistical analysis of Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00310791).
- ADVISEIndependent statistical analysis of A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…